PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
19-Sep-2024 Bayer submits application to MHRA for elinzanetant to treat moderate to severe vasomotor systems associated with menopause in women Bayer
19-Sep-2024 Biocomposites acquires remaining shares in manufacturers of SYNICEMTM and Subiton products Biocomposites
19-Sep-2024 New Data for BRIUMVI® (ublituximab-xiiy) Demonstrate that 92% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 5 Years of Treatment TG THERAPEUTICS
19-Sep-2024 Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease Tiziana Life Sciences
19-Sep-2024 Aston Institute for Membrane Excellence celebrates official launch with multidisciplinary event Aston University
19-Sep-2024 Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer Autolus Therapeutics plc
19-Sep-2024 New Data for BRIUMVI® (ublituximab-xiiy) Demonstrate that 92% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 5 Years of Treatment TG THERAPEUTICS
19-Sep-2024 Biognosys Enters Reselling Agreement for Spectronaut Proteomics Software with Leading Provider of Mass Spectrometry Systems Biognosys
19-Sep-2024 Ketabon To Present Advancements In At-Home Ketamine Therapy For Treatment-Resistant Depression At ECNP Congress 2024 Ketabon GmbH
19-Sep-2024 ScaleReady announces a G-Rex® Grant has been awarded to ImmunoScape Wilson Wolf Manufacturing
19-Sep-2024 OEAW AND BOEHRINGER INGELHEIM FOUNDATION ESTABLISH NEW INSTITUTE FOR BIOMEDICAL ARTI-FICIAL INTELLIGENCE IN VIENNA Boehringer Ingelheim
19-Sep-2024 Fasenra approved in the US for eosinophilic granulomatosis with polyangiitis AstraZeneca
19-Sep-2024 Semaglutide improves outcomes for obese patients with common skin condition, new study shows European Academy of Dermatology and Venereology
19-Sep-2024 MHRA grants Benilexa® One Handed (52mg levonorgestrel intrauterine system [IUS]) an 8-year licence for contraception in the UK Gedeon Richter UK Ltd
19-Sep-2024 Biocomposites acquires remaining shares in manufacturers of SYNICEMTM and Subiton products Biocomposites
19-Sep-2024 Poolbeg Pharma plc - Interim results for the six months to 30 June 2024 Poolbeg Pharma plc
19-Sep-2024 New drug target discovered for aggressive form of prostate cancer Institute of Cancer Research
17-Sep-2024 AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease AC Immune SA
17-Sep-2024 Improved breast cancer risk tools on the horizon as major study reaches 20-year halfway point The Institute of Cancer Research
17-Sep-2024 Arca BioLogistics Partners with Cen Global to Propel Bio-Science Logistics into The 21st Century Arca BioLogistics